Scientific & Professional Training
Comprehensive Pneumology Center
Tell me and I forget, teach me and I remember, involve me and I learn.
Creating a unique structured translational training and education platform to ultimately raise future (clinician-)scientist leaders in respiratory medicine and science. Read more...
PD Dr. Claudia Staab-Weijnitz from the Institute of Lung Biology and Disease (ILBD) and Comprehensive Pneumology Center (CPC) has been invited to join...
Learn about cutting-edge seq techniques from the experts in the local scientific community in an informal half-day symposium.
It is our sincere pleasure to announce the next German-French Lung Retreat, which will take place in Paris right before the ERS International Congress...
Carolina Ballester Lopez, PhD student in Ali Önder Yildirim's Lab ”Immunopathology of COPD” at the ILBD/CPC received an International Trainee...
Arunima Sengupta, PhD student in the core unit "Live Cell Imaging" at the iLBD/CPC and directly supervised by Dr. Gerald Burgstaller, received an...
The MD/PhD Program at the Comprehensive Pneumology Center (CPC) aims to create a unique translational training and education platform to ultimately raise future (clinician-)scientist leaders in respiratory medicine and science.
The program benefits from its supporting partners - the Helmholtz Zentrum München - German Research Center for Environmental Health - and the Ludwig-Maximilians-University and the university hospital system - thereby providing an excellent and inspiring environment for translational research.
Moreover, the Scientific Director, Dr. Claudia Staab-Weijnitz, and Program Coordinator, Dr. Doreen Franke, are supported by an advisory board that includes representatives of all main stakeholders from the Institute of Lung Biology and Disease, Research Unit Lung Repair and Regeneration, and Institute of Epidemiology at the Helmholtz Zentrum München.
(Clinician-)Scientists trained within the program have diverse career options in the expanding biomedical field, and will undoubtedly be able to advance our understanding of lung disease and develop novel therapies for improving the care and quality of life of patients suffering from lung disease.